XML 18 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Income Statement [Abstract]      
Product revenue $ 1,747 $ 1,069 $ 490
Other revenues     300
Total revenue 1,747 1,069 790
Cost of goods sold (462) (291) (464)
Gross profit 1,285 778 326
Operating expenses:      
Selling, general and administrative expenses 10,009 15,783 20,657
Research and development costs 6,486 4,299 12,688
Total operating expenses 16,495 20,082 33,345
Operating loss (15,210) (19,304) (33,019)
Derivative instrument income 564 1,942 2,756
Interest income 9 5 20
Other (expense) income and interest expense (67) (24) (81)
Net loss $ (14,704) $ (17,381) $ (30,324)
Common share data:      
Basic loss per share [1] $ (0.91) $ (1.84) $ (4.81)
Diluted loss per share [1] $ (0.91) $ (1.84) $ (5.10)
Weighted average number of basic shares outstanding [1] 16,161,687 9,452,050 6,300,614
Weighted average number of diluted shares outstanding [1] 16,161,687 9,452,050 6,569,011
Other comprehensive income (loss):      
Foreign currency translation adjustments $ (28) $ (76) $ 59
Comprehensive Loss $ (14,732) $ (17,457) $ (30,265)
[1] Reflects a one-for-sixteen (1:16) reverse stock split effected on April 8, 2014.